These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19170024)

  • 1. An animal model of premenstrual dysphoric disorder sensitive to antidepressants.
    Schneider T; Popik P
    Curr Protoc Neurosci; 2009 Jan; Chapter 9():Unit 9.31. PubMed ID: 19170024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants.
    Schneider T; Popik P
    Psychoneuroendocrinology; 2007 Jul; 32(6):651-9. PubMed ID: 17561352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
    Pearlstein T; Yonkers KA
    Expert Opin Pharmacother; 2002 Jul; 3(7):979-91. PubMed ID: 12083997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
    Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
    Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sertraline in the treatment of premenstrual dysphoric disorder].
    Culav-Sumić J; Skocilić Z; Jukić V
    Lijec Vjesn; 1999; 121(7-8):234-8. PubMed ID: 10573958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resident intruder paradigm-induced PMDD rat model of premenstrual irritability: behavioral phenotypes, drug intervention, and biomarkers.
    Gao M; Zhang H; Gao Z; Sun Y; Xu G; Wei F; Wang J; Gao D
    Aging (Albany NY); 2022 Nov; 14(22):9210-9220. PubMed ID: 36441533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
    Freeman EW
    CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?
    Ho HP; Olsson M; Westberg L; Melke J; Eriksson E
    Neuropsychopharmacology; 2001 May; 24(5):502-10. PubMed ID: 11282250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine in the treatment of premenstrual dysphoric disorder.
    Carr RR; Ensom MH
    Ann Pharmacother; 2002 Apr; 36(4):713-7. PubMed ID: 11918525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating premenstrual dysphoric disorder using serotonin agents.
    Lin J; Thompson DS
    J Womens Health Gend Based Med; 2001 Oct; 10(8):745-50. PubMed ID: 11703886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SSRIs for premenstrual dysphoric disorder.
    Drug Ther Bull; 2002 Sep; 40(9):70-2. PubMed ID: 12298224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A forced swim-based rat model of premenstrual depression: effects of hormonal changes and drug intervention.
    Wei S; Geng X; Li Z; Xu K; Hu M; Wu H; Shi W; Qiao M
    Aging (Albany NY); 2020 Nov; 12(23):24357-24370. PubMed ID: 33229622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
    Steiner M; Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 12():17-21. PubMed ID: 11041380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Premenstrual dysphoric disorder. An overview of diagnosis, epidemiology and therapeutic approaches].
    Lenzinger E; Diamant K; Vytiska-Binstorfer E; Kasper S
    Nervenarzt; 1997 Sep; 68(9):708-18. PubMed ID: 9411273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.
    Freeman EW
    Curr Psychiatry Rep; 2002 Dec; 4(6):435-40. PubMed ID: 12441023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
    Sundström-Poromaa I; Comasco E
    CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.
    Li Y; Raaby KF; Sánchez C; Gulinello M
    Behav Brain Res; 2013 Nov; 256():520-8. PubMed ID: 24016840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAZ in the treatment of premenstrual dysphoric disorder.
    Rapkin AJ
    J Reprod Med; 2008 Sep; 53(9 Suppl):729-41. PubMed ID: 18980045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.